Main > ONCOLOGY (**) > Carcinoid Syndrome *** > Treatment > Co: FR. I. Lanreotide Acetate Inj.

---

Co: FR. I. Lanreotide Acetate Inj.'s subsections
(*) USA Approval Date: 2017. 09.10
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2018. 11.20.
TradeMark
TradeMark Web-Site

Co: FR. I. Lanreotide Acetate Inj.'s products
This section has no products